To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer

NCT05491694 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
TNBC - Triple-Negative Breast Cancer

Interventions

DRUG: Toripalimab
DRUG: Epirubicin
PROCEDURE: High Intensity Focused Ultrasoun
DRUG: Cyclophosphamide
DRUG: Carboplatin
DRUG: Nab-paclitaxel

Sponsor

The First Affiliated Hospital with Nanjing Medical University